Kiniksa Pharmaceuticals, Ltd. Banner Image

Kiniksa Pharmaceuticals, Ltd.

  • Ticker KNSA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kiniksa Pharmaceuticals, Ltd. Logo Image
  • 51-200 Employees
  • Based in Lexington, Massachusetts
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underservedMore conditions and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways that are implicated across a spectrum of diseases.
4.8 / 5.0 (132)

Kiniksa Pharmaceuticals, Ltd. reports have an aggregate usefulness score of 4.8 based on 132 reviews.

Kiniksa Pharmaceuticals, Ltd.

Most Recent Annual Report

Kiniksa Pharmaceuticals, Ltd.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Kiniksa Pharmaceuticals, Ltd. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!